Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02279420 · ClinicalTrials.gov registry record · NA

ESSENTIAL Trial™ Sham Cross-over

A NA study of Obesity, sponsored by USGI Medical.

Completed
Registry status
NA
Development phase
73
Enrollment target
11
Study locations

NCT02279420 is a NA study of Obesity that has completed, run by USGI Medical. The registered enrollment target is 73 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower). The trial reports 11 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02279420, a NA study of Obesity, has completed, sponsored by USGI Medical.

COMPLETED
Registry status
NA
Development phase
73 participants
Enrollment target
11
Study locations

Study Summary

This is a multicenter, un-blinded, open label, pivotal supplemental study to G130163 intended to evaluate the safety and efficacy of treating previous sham subjects in the Essential pivotal trial (IDE#G130163) with the active treatment (the placement of g-Cath EZ suture anchors along with diet and exercise). Compliant sham subjects (those who attended all primary IDE follow-up visits AND who continue to meet eligibility criteria as described in this protocol) will be offered this active treatment after their 12 month unblinding visit in the Essential pivotal trial.

Conditions Studied

Interventions

  • DEVICE g-Cath EZ™ Suture Anchor Delivery Catheter

Study Locations (11)

Missouri

  • Saint Luke's Hospital - Kansas City
  • WA University School of Medicine - St Louis

Arizona

  • Shea Campus -Scottsdale Healthcare - Scottsdale

Florida

  • University of Miami Hospital - Miami

Georgia

  • Hamilton Medical Center - Dalton

Illinois

  • Northshore/Evanston Hospital - Evanston

Louisiana

  • Crescent City Surgical - Metairie

Massachusetts

  • Brigham & Women's Hospital - Boston

Minnesota

  • Fairview UMMC-University - Minneapolis

Trial Details

FieldValue
Enrollment Target 73 participants
Start Date 2015-01-05
Est. Completion 2016-09-30
Phase NA

Sponsor

USGI Medical

7 total trials

What the Registry Record Tells You About NCT02279420

The ClinicalTrials.gov registry entry for NCT02279420 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower). The listed sponsor is USGI Medical, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which g-Cath EZ™ Suture Anchor Delivery Catheter is the first listed.

NCT02279420 reports 11 study locations spanning 10 distinct geographic areas - top geographies include Missouri, Arizona, Florida.

Frequently Asked Questions

What is clinical trial NCT02279420 about?

NCT02279420 is a clinical study titled "ESSENTIAL Trial™ Sham Cross-over". This is a multicenter, un-blinded, open label, pivotal supplemental study to G130163 intended to evaluate the safety and efficacy of treating previous sham subjects in the Essential pivotal trial (IDE#G130163) with the active treatment (the placement of g-Cath EZ suture anchors along with diet and e...

What is the current status of trial NCT02279420?

This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2015-01-05. Estimated completion is 2016-09-30.

What conditions does trial NCT02279420 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT02279420?

The interventions under investigation include: g-Cath EZ™ Suture Anchor Delivery Catheter (DEVICE).

Who is sponsoring clinical trial NCT02279420?

This trial is sponsored by USGI Medical, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02279420 being conducted?

This trial has 11 study locations across Arizona, Florida, Georgia, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.